Befesa logra un beneficio de 45 millones en el primer semestre, un 12,4% más, y confirma previsiones

Grifols shares rose nearly 5% during Wednesday's early trading session following the company's announcement of its first-half financial results. The pharmaceutical firm reported a net profit of 227 million euros, marking a 28.7% increase compared to the same period last year. In addition to the profit growth, the company reaffirmed its financial guidance for the remainder of the fiscal year.

This performance aligns with a broader trend of mid-year financial reporting among major European corporations. Other entities, including Telefónica, UBS, and Deutsche Bank, have also released their first-half results, highlighting varied financial outcomes ranging from significant loss reductions to record-breaking profit margins and planned share buybacks.